These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1911040)

  • 21. Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes.
    Whiteside TL; Heo DS; Takagi S; Herberman RB
    Immunol Ser; 1989; 48():139-57. PubMed ID: 2488318
    [No Abstract]   [Full Text] [Related]  

  • 22. [A clinical study on adoptive immunotherapy of bone metastatic neoplasm with tumor infiltrating lymphocytes].
    Hua JM; Zheng ZG; Xu GD
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):203-6. PubMed ID: 7956700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New perspectives in immunotherapy of leukemia.
    Lotzová E
    Immunol Ser; 1994; 61():231-8. PubMed ID: 8011747
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic approaches to adoptive cellular therapy of malignancy.
    Arca MJ; Mulé JJ; Chang AE
    Semin Oncol; 1996 Feb; 23(1):108-17. PubMed ID: 8607021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction.
    Abe J; Wakimoto H; Tsunoda R; Okabe S; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
    Biochem Biophys Res Commun; 1996 Jan; 218(1):164-70. PubMed ID: 8573124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive T-cell immunotherapy of cancer.
    Li Q; Chang AE
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):105-17. PubMed ID: 10515683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.
    Berry LJ; Moeller M; Darcy PK
    Tissue Antigens; 2009 Oct; 74(4):277-89. PubMed ID: 19775368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study on immunotherapy of ovarian cancer with tumor infiltrating lymphocytes].
    Hua Z; Lu J; Li H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):555-7. PubMed ID: 9275430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR; Wroblewski JM
    Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.
    Semino C; Martini L; Queirolo P; Cangemi G; Costa R; Alloisio A; Ferlazzo G; Sertoli MR; Reali UM; Ratto GB; Melioli G
    Anticancer Res; 1999; 19(6C):5645-9. PubMed ID: 10697634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically marking human cells--results of the first clinical gene transfer studies.
    Cai Q; Rubin JT; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):125-36. PubMed ID: 7621260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotherapy of tumors: from the first experimental studies to the recent clinical applications. I. Passive immunotherapy].
    Burrai I; Di Lallo A
    Minerva Med; 1991 Sep; 82(9):519-28. PubMed ID: 1944999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 2 in cancer therapy.
    Testa U; Montesoro E; Bulgarini D; Samoggia P; Masciulli R; Habetswallner D; Carè A; Mariani G; Giannella G; Boccoli G
    Ann Ist Super Sanita; 1990; 26(3-4):283-334. PubMed ID: 2091501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-derived activated cells: culture conditions and characterization.
    Maleckar JR; Friddell CS; Lewko WM; Yannelli JR; West WH; Oldham RK
    Immunol Ser; 1989; 48():159-73. PubMed ID: 2488319
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular immunotherapy of cancer.
    Yang JC
    Curr Opin Gen Surg; 1994; ():238-44. PubMed ID: 7583979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new therapeutic concept in the treatment of metastatic cancers of the kidney: the TIL (tumor infiltrating lymphocytes)].
    Peyret C
    J Urol (Paris); 1991; 97(2):63-71. PubMed ID: 2071925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer.
    Gomez GG; Hutchison RB; Kruse CA
    Cancer Treat Rev; 2001 Dec; 27(6):375-402. PubMed ID: 11908930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.
    Hwu P; Rosenberg SA
    Cancer Detect Prev; 1994; 18(1):43-50. PubMed ID: 8162605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer.
    Aoki Y; Takakuwa K; Kodama S; Tanaka K; Takahashi M; Tokunaga A; Takahashi T
    Cancer Res; 1991 Apr; 51(7):1934-9. PubMed ID: 2004379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.